Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEducational Exhibits

Role of radioactive iodine uptake in management of thyroid disease

Hussein Farghaly
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1025;
Hussein Farghaly
1Radiology-Nuclear Medicine Divison, Riyadh Military Hospital, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1025

Learning Objectives 1. To demonstrate the role of radioactive iodine uptake (RAIU) in diagnosis and therapy of thyroid diseases. 2. To demonstrate different tracers and techniques used for RAIU.

In RAIU I-131 or I-123 administrate orally in a capsule or in liquid form. Medication that might interfere with thyroid uptake should be discontinued for an appropriate length of time and patient should have fasting for 4 hours prior the study. The RAIU at various intervals of time is measured using a gamma scintillation counter or camera based. The percentage of RAIU 24 hours after the administration of RAI is most useful, since in most instances the thyroid gland has reached the plateau of isotope accumulation, and in this time, the best separation between high, normal, and low uptake is obtained. RAIU at 2-6 hours is also done to detect thyroid gland with rapid iodine turnover. Normal values for 24-hour RAIU in most parts of North America are 5 to 30”% percent. In many other parts of the world, normal values range from 15 to 50 %. The main indications of RAIU includes, differential diagnosis of thyrotoxicosis (TOX), estimate the therapeutic dose in Graves’ disease (GD) and in thyroid cancer together with whole body scan estimate residual thyroid post surgery, estimate I-131 therapy effectiveness and follow-up for recurrence. In TOX, RAIU can differentiate between causes with decreased thyroidal RAIU which typically encountered in the syndrome of transient thyrotoxicosis (both de Quervain's and painless thyroiditis), thyrotoxicosis factitia, Amiodarone-induced TOX (type II is near zero and type I may be elevated) and iodide-induced TOX (Jod-Basedow disease) and causes with elevated RAIU as in GD, multinodular toxic goiter or hasitoxicosis. Tc-99m thyroid uptake may be use as alternative to RAIUI with favorable radiation dosimetry and short study length (30 min) however it is not suitable for calculating RAI therapeutic dose. I will demonstrate some example cases for RAIU in different thyroid disease

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of radioactive iodine uptake in management of thyroid disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Role of radioactive iodine uptake in management of thyroid disease
Hussein Farghaly
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1025;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of radioactive iodine uptake in management of thyroid disease
Hussein Farghaly
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1025;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Educational Exhibits

  • Do They Work? Utilizing the "Hoshin Kanri" Process in the Nuclear Medicine Department
  • Challenges in F-18 FDG PET/CT: Benign Osseous Hypermetabolic Lesions
  • Early small bowel activity may predict rapid gastric transit on gastric emptying scintigraphy
Show more Educational Exhibits

MTA I: Educational Exhibits-General Clinical Specialties

  • Clinically significant incidental findings discovered on nuclear medicine imaging
  • Recognizing the artifacts and minimizing untoward effects caused by failed or complicated radiopharmaceutical injections
  • Evaluation of Roux-en-Y gastric bypass with hepatobiliary scans
Show more MTA I: Educational Exhibits-General Clinical Specialties

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire